- ►diabetesjournals.org AH Heald, KW Siddals, W Fraser, W Taylor, K … - Diabetes, 2002 - Am Diabetes Assoc The IGF system is increasingly implicated in the development of cardiovascular
disease. The effects of circulating IGFs on the vasculature are largely
modulated by IGFBPs, which control their access to cell-surface IGF ... Cited by 41 - Related articles - BL Direct - All 4 versions
- Free from Publisher ES Leinonen, JT Salonen, RM Salonen, RA … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 239 type 2 diabetic participants in the
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study (76 women)
aged 50–75 years were examined before fenofibrate intervention. Patients ... Cited by 22 - Related articles - BL Direct - All 7 versions
AH Heald, JK Cruickshank, LK Riste, JE Cade … - Diabetologia, 2001 - Springer Cardiovascular disease is the leading cause of mor- bidity and mortality in
patients with Type II (non-in- sulin-dependent) diabetes mellitus accounting for
up to 75% of deaths [1]. Although insulin and insulin re- sistance have ... Cited by 88 - Related articles - BL Direct - All 4 versions
JM Gibson, M Westwood, RJ Young, A White - Journal of Clinical Endocrinology & Metabolism, 1996 - Endocrine Soc Journal of Clinical Endocrinology and Metabolism Copyright 0 1996 by The
Endocrine Society ... REDUCED INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-l
(IGFBP-1) LEVELS CORRELATE WITH INCREASED CARDIOVASCULAR RISK IN NON- ... Cited by 53 - Related articles - All 5 versions
V Mohamed-Ali, IN Pinkney, A Panahloo, S … - CLINICAL ENDOCRINOLOGY-OXFORD-, 1999 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 53 - Related articles - BL Direct - All 3 versions
AL Undén, S Elofsson, K Brismar - Clinical Endocrinology-Oxford, 2005 - medscape.com A possible involvement of insulin-like growth factor-I (IGF-I) and its binding
protein IGFBP-1 in the pathogenesis of cardiovascular disorder has been
suggested. [1–3] Total IGF-I levels are lower in patients with an ... Cited by 18 - Related articles - All 9 versions
M Harrela, Q Qiao, R Koistinen, J Tuomilehto … - Horm Metab Res, 2002 - thieme-connect.com Insulin-like growth factor binding protein-1 (IGFBP-1) has been implicated in
the development of cardiovascular disease, but it is not known whether IGFBP-1
is related to cardiovascular mortality. We examined the relation of ... Cited by 27 - Related articles - All 5 versions
M Wallander, K Brismar, J Öhrvik, L Ryden, … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis Low levels of IGF-I are associated with increased risk
of cardiovascular disease and type 2 diabetes. The aim of this study was to
investigate the IGF-I system in patients with acute myocardial infarction ... Cited by 10 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org J Janssen, RP Stolk, HAP Pols, DE Grobbee, … - Arteriosclerosis, thrombosis, and vascular biology, 1998 - Am Heart Assoc Abstract—Recently, a method to measure free insulin-like growth factor-I
(IGF-I) levels has been developed. Free IGF-I levels may have greater
physiological and clinical relevance than total (bound and free) IGF-I. The ... Cited by 119 - Related articles - BL Direct - All 5 versions
- ►eje-online.org [PDF] JA Janssen, SW Lamberts - European journal of endocrinology, 2002 - EFES The incidence of peripheral, cerebro- and cardiovascular disease (CVD) in
patients with type 2 dia- betes mellitus is approximately twice as high as in
the non-diabetic population. Conventional cardio- vascular risk factors ... Cited by 46 - Related articles - BL Direct - All 10 versions
